Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N05 PSYCHOLEPTICS
N05A ANTIPSYCHOTICS
N05AE Indole derivatives
N05AE04 Ziprasidone
D01939 Ziprasidone hydrochloride (USP) <US>
USP drug classification [BR:br08302]
Antipsychotics
2nd Generation/Atypical
Ziprasidone
D01939 Ziprasidone hydrochloride (USP)
Bipolar Agents
Bipolar Agents, Other
Ziprasidone
D01939 Ziprasidone hydrochloride (USP)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01478 Dopamine antagonist
DG01474 Dopamine D2-receptor antagonist
DG00892 Ziprasidone
D01939 Ziprasidone hydrochloride
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Dopamine
DRD2
D01939 Ziprasidone hydrochloride (USP) <US>
Serotonin
HTR2A
D01939 Ziprasidone hydrochloride (USP) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D01939
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D01939
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01478 Dopamine antagonist
DG01474 Dopamine D2-receptor antagonist
DG00892 Ziprasidone